London – October 14, 2013 – L.E.K. Consulting has been named “Management Consultant of the Year” for the second consecutive year at the 2013 Independent Healthcare Awards. The awards, run by Laing & Buisson, highlight the range of achievements within the sector and pay tribute to those individuals and teams which have demonstrated outstanding excellence over time.
Jonathan Sparey, Head of European Healthcare at L.E.K. Consulting, commented: “Winning this award for the second consecutive year demonstrates L.E.K.’s continued commitment to its clients in the healthcare sector and is a testament to the quality of our work and the experience of our team. Our commercial advice and insight enables clients across the spectrum of healthcare provision to achieve real competitive advantage through the development and implementation of innovative strategies, and through the completion of transformational transactions.”
Other recent awards for L.E.K.’s healthcare practice include HealthInvestor Strategy Consultants of the Year 2013, HealthInvestor Consultants of the Year 2011, and Acquisitions Monthly Healthcare Sector Advisor of the Year 2011. Jonathan Sparey has also been named in the HealthInvestor Power 50 list in 2013 and 2012, and L.E.K. was named City A.M. Professional Services Firm of the Year in 2011 for its work across all sectors of the economy.
About L.E.K. Consulting’s Healthcare and Life Sciences Practice
L.E.K. Consulting is an international firm that specializes in strategy, transaction services and performance improvement consulting. It advises the largest private and public sector organizations, private equity companies and smaller, more entrepreneurial businesses.
L.E.K.’s partner-led teams combine deep commercial and sector experience with a highly analytical approach to solving business problems. The firm provides corporate and private equity clients with strategy, transaction support and performance improvement consulting, covering the full breadth of the healthcare sector, including healthcare services, life sciences, biotechnology, medtech and pharmaceuticals. The firm has completed more than 3,000 health sector projects globally since it was founded in 1983, of which more than 1,000 were transaction-related.
Find out more here.